The Karolinska Institutet (KI) is one of the world´s leading medical universities; its mission is to improve human health through research and education. Founded in 1810 by King Karl XIII, the KI now accounts for over 40 percent of the medical academic research conducted in Sweden and offers the country´s broadest range of education in medicine and the health sciences. Since 1901, the Nobel Assembly at the KI has selected the Nobel laureates in Physiology or Medicine. The KI offers the widest range of medical education in Sweden, including research, clinical training, and other training within the healthcare system.
Approximately 5,500 students are currently enrolled at the Bachelor’s and Master’s level, and over 350 students receive their PhDs from the KI annually. Teachers often carry out research in parallel with teaching, ensuring that students are exposed to the latest medical advances. The KI also offers excellent opportunities for international exchange, which gives students the chance to work and study abroad.
Research at the KI spans the entire medical field, from basic experimental research to patient-oriented and nursing research. Fields of study include cancer; cardiovascular disease; care sciences; endocrinology and metabolism; immunology, infection, and inflammation; neuroscience; and public health. Research is conducted in 22 departments, most of which are situated or adjacent to Stockholm's teaching hospitals. This creates ample opportunity for translational research in which new experimental results can rapidly benefit patients, and where clinical observations provide the foundation for novel research avenues. The KI also has collaboration agreements in research and education with a large number of universities worldwide, with companies in the biomedical and biotechnology sectors, as well as with individual countries.